tiprankstipranks
Innovent Biologics (HK:1801)
:1801
Hong Kong Market

Innovent Biologics (1801) Cash flow

Compare
10 Followers

Innovent Biologics Cash Flow

HK:1801's free cash flow for Q2 2024 was ¥-915.15M. For the 2024 fiscal year, HK:1801's free cash flow was decreased by ¥2.06B and operating cash flow was ¥-215.63M. See a summary of the company’s cash flow.
Cash Flow
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
¥ 147.81M¥ -1.92B¥ -2.02B¥ -307.69M¥ -1.66B
Investing Cash Flow
¥ -998.66M¥ -1.44B¥ -2.70B¥ -5.18B¥ -2.57B
Financing Cash Flow
¥ 2.59B¥ 2.89B¥ 5.00B¥ 4.91B¥ 2.11B
End Cash Position
¥ 2.75B¥ 1.02B¥ 1.36B¥ 1.28B¥ 2.43B
Free Cash Flow
¥ -1.24B¥ -3.30B¥ -3.87B¥ -1.08B¥ -2.03B
Currency in CNY

Innovent Biologics Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis